Related Party Transactions	9 Months Ended
Jul. 31, 2020
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 5 RELATED PARTY TRANSACTIONS As of July 31, 2020 and October 31, 2019, the Company owed a stockholder $867,645 and $824,705 respectively which are unsecured and repayable on demand. Interests are charged at 7% per annum on the amount owed. As of July 31, 2020 and October 31, 2019, the Company owed four related parties a total of $5,083,314 and $4,916,638 respectively which are unsecured and repayable on demand. Interests are charged at 7% per annum on the amounts owed. Total interest expenses on advances from a stockholder and the related parties accrued for the three and nine months ended July 31, 2020 and 2019 were $79,615, $79,846, $239,946, and $234,816 respectively. As of July 31, 2020 and October 31, 2019, the Company owed $299,195 and $280,514 respectively, to two directors for advances made on an unsecured basis, repayable on demand and interest free. Imputed interest charged at 5% per annum on the amounts owed to two directors is $3,409, $3,189, $10,205 and $9,544 for the three and nine months ended July 31, 2020 and 2019 respectively. Sales for the three and nine months ended 31 July 2020 and 2019 of US$961, nil, US$48,491 and nil respectively were made to a company in which Mr. Chen Tie Jun has a significant equity interest.

Related Party Transactions

9 Months Ended

Jul. 31, 2020

NOTE 5 RELATED PARTY TRANSACTIONS

As of July 31, 2020 and October 31, 2019, the Company owed a stockholder $867,645 and $824,705 respectively which are unsecured and repayable on demand. Interests are charged at 7% per annum on the amount owed.

As of July 31, 2020 and October 31, 2019, the Company owed four related parties a total of $5,083,314 and $4,916,638 respectively which are unsecured and repayable on demand. Interests are charged at 7% per annum on the amounts owed.

Total interest expenses on advances from a stockholder and the related parties accrued for the three and nine months ended July 31, 2020 and 2019 were $79,615, $79,846, $239,946, and $234,816 respectively.

As of July 31, 2020 and October 31, 2019, the Company owed $299,195 and $280,514 respectively, to two directors for advances made on an unsecured basis, repayable on demand and interest free.

Imputed interest charged at 5% per annum on the amounts owed to two directors is $3,409, $3,189, $10,205 and $9,544 for the three and nine months ended July 31, 2020 and 2019 respectively.

Sales for the three and nine months ended 31 July 2020 and 2019 of US$961, nil, US$48,491 and nil respectively were made to a company in which Mr. Chen Tie Jun has a significant equity interest.

Advanced Biomedical Technologies Inc. 10-Q